Rokos Capital Management’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-840,630
| Closed | -$1.37M | – | 68 |
|
|
2024
Q2 | $1.37M | Hold |
840,630
| – | – | 0.01% | 72 |
|
|
2024
Q1 | $4.3M | Hold |
840,630
| – | – | 0.02% | 63 |
|
|
2023
Q4 | $4.8M | Sell |
840,630
-1,907,509
| -69% | -$10.9M | 0.04% | 41 |
|
|
2023
Q3 | $13.3M | Hold |
2,748,139
| – | – | 0.1% | 43 |
|
|
2023
Q2 | $11.2M | Hold |
2,748,139
| – | – | 0.11% | 39 |
|
|
2023
Q1 | $14.1M | Hold |
2,748,139
| – | – | 1.04% | 19 |
|
|
2022
Q4 | $17.3M | Buy |
2,748,139
+840,630
| +44% | +$5.29M | 0.76% | 13 |
|
|
2022
Q3 | $20.8M | Hold |
1,907,509
| – | – | 0.62% | 17 |
|
|
2022
Q2 | $10.6M | Buy |
1,907,509
+1,058,175
| +125% | +$5.88M | 0.31% | 34 |
|
|
2022
Q1 | $7.9M | Buy |
849,334
+278,975
| +49% | +$2.59M | 0.37% | 30 |
|
|
2021
Q4 | $8.6M | Buy |
570,359
+220,386
| +63% | +$3.32M | 0.52% | 17 |
|
|
2021
Q3 | $8.2M | Buy |
+349,973
| New | +$8.2M | 0.18% | 17 |
|